ZA937993B - 6-(substituted methylene) penems and intermediates - Google Patents

6-(substituted methylene) penems and intermediates

Info

Publication number
ZA937993B
ZA937993B ZA937993A ZA937993A ZA937993B ZA 937993 B ZA937993 B ZA 937993B ZA 937993 A ZA937993 A ZA 937993A ZA 937993 A ZA937993 A ZA 937993A ZA 937993 B ZA937993 B ZA 937993B
Authority
ZA
South Africa
Prior art keywords
penems
intermediates
substituted methylene
methylene
substituted
Prior art date
Application number
ZA937993A
Other languages
English (en)
Inventor
Nigel John Perryman Broom
Frank Peter Harrington
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA937993B publication Critical patent/ZA937993B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Ink Jet (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA937993A 1992-10-29 1993-10-27 6-(substituted methylene) penems and intermediates ZA937993B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929222700A GB9222700D0 (en) 1992-10-29 1992-10-29 Chemical compounds

Publications (1)

Publication Number Publication Date
ZA937993B true ZA937993B (en) 1995-03-22

Family

ID=10724235

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA937993A ZA937993B (en) 1992-10-29 1993-10-27 6-(substituted methylene) penems and intermediates

Country Status (35)

Country Link
US (3) US5602250A (sv)
EP (1) EP0666862B1 (sv)
JP (1) JP3488457B2 (sv)
KR (1) KR100295710B1 (sv)
CN (3) CN1044247C (sv)
AP (1) AP438A (sv)
AT (1) ATE191914T1 (sv)
AU (1) AU687365B2 (sv)
BR (1) BR1100542A (sv)
CA (1) CA2147755C (sv)
CZ (1) CZ293106B6 (sv)
DE (1) DE69328436T2 (sv)
DK (1) DK0666862T3 (sv)
ES (1) ES2145064T3 (sv)
FI (1) FI114638B (sv)
GB (1) GB9222700D0 (sv)
GR (1) GR3033448T3 (sv)
HK (1) HK1012375A1 (sv)
HU (1) HUT71467A (sv)
IL (1) IL107431A (sv)
MA (1) MA23017A1 (sv)
MX (1) MX9306679A (sv)
MY (1) MY117265A (sv)
NO (1) NO306903B1 (sv)
NZ (1) NZ257109A (sv)
PH (1) PH30919A (sv)
PL (1) PL177840B1 (sv)
PT (1) PT666862E (sv)
RU (1) RU2133750C1 (sv)
SA (1) SA93140373B1 (sv)
SI (1) SI9300574A (sv)
SK (1) SK281870B6 (sv)
TW (1) TW400332B (sv)
WO (1) WO1994010178A1 (sv)
ZA (1) ZA937993B (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9222700D0 (en) * 1992-10-29 1992-12-09 Smithkline Beecham Plc Chemical compounds
GB9326248D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Plc Pharmaceutical formulations
US6472383B1 (en) 1994-04-25 2002-10-29 Smithkline Beecham P.L.C. Pharmaceutical formulations
WO1995028935A1 (en) * 1994-04-25 1995-11-02 Smithkline Beecham Plc Pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections
US6969303B1 (en) * 1994-10-12 2005-11-29 Nextec, Inc. Method and composition for removing coatings which contain hazardous elements
AU2001225605A1 (en) * 2000-10-03 2002-04-15 Elena Alexandrovna Izakson Thiazine derivatives
DK1425001T3 (da) 2001-09-14 2009-04-14 Glaxo Group Ltd Phenethanolaminderivater til behandling af respiratoriske sygdomme
AR039475A1 (es) 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
AR039476A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp Proceso para preparar derivados de 6-alquiliden penem
AR039774A1 (es) 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
FR2844807B1 (fr) * 2002-09-23 2005-11-11 Rambach Alain Procede de detection de microorganismes resistants a la meticilline
CA2525507A1 (en) * 2003-05-16 2004-12-02 Wyeth Holdings Corporation Process for synthesizing .beta.-lactamase inhibitor intermediates
TW200716102A (en) * 2005-06-01 2007-05-01 Wyeth Corp Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors
CA2632149C (en) * 2005-12-01 2011-11-15 Pfizer Products Inc. Pyrimidine derivatives for the treatment of abnormal cell growth
EP2316821A1 (en) * 2009-10-27 2011-05-04 Novartis AG Process for the manufacture of organic compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2541924A (en) * 1948-09-17 1951-02-13 Lilly Co Eli Synthesis of substituted imidazoles
GB1403841A (en) * 1973-03-22 1975-08-28 Ici Ltd Imidazo heterocyclic derivatives
US4137320A (en) * 1974-02-07 1979-01-30 Plantex, Ltd. Pharmaceutical compositions containing imidazo(2,1-b)thiazoles and process for reducing blood sugar levels therewith
DE2949167A1 (de) * 1978-12-08 1980-06-26 Ciba Geigy Ag Photographisches material fuer das silberfarbbleichverfahren
FI82471C (sv) * 1984-01-26 1991-03-11 Beecham Group Plc Förfarande för framställning av farmakologiskt aktiva 6-metylenpenemde rivater
US5015473A (en) * 1984-01-30 1991-05-14 Pfizer Inc. 6-(substituted)methylenepenicillanic and 6-(substituted)hydroxymethylpenicillanic acids and derivatives thereof
GB8518416D0 (en) * 1985-07-22 1985-08-29 Beecham Group Plc Compounds
GB8518421D0 (en) * 1985-07-22 1985-08-29 Beecham Group Plc Compounds
GB9222700D0 (en) * 1992-10-29 1992-12-09 Smithkline Beecham Plc Chemical compounds
AU1054297A (en) 1995-11-08 1997-05-29 Smithkline Beecham Corporation A process of making 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives

Also Published As

Publication number Publication date
TW400332B (en) 2000-08-01
PH30919A (en) 1997-12-23
AU5335594A (en) 1994-05-24
SK281870B6 (sk) 2001-08-06
CZ105395A3 (en) 1996-04-17
NO306903B1 (no) 2000-01-10
PT666862E (pt) 2000-08-31
JPH08502504A (ja) 1996-03-19
AP9300585A0 (en) 1993-10-31
HUT71467A (en) 1995-11-28
CN1227842A (zh) 1999-09-08
MA23017A1 (fr) 1994-07-01
RU2133750C1 (ru) 1999-07-27
CA2147755C (en) 2004-12-07
CN1089267A (zh) 1994-07-13
BR1100542A (pt) 2002-04-02
NZ257109A (en) 1997-01-29
CN1102595C (zh) 2003-03-05
HU9501226D0 (en) 1995-06-28
KR950704332A (ko) 1995-11-17
CA2147755A1 (en) 1994-05-11
MY117265A (en) 2004-06-30
US6037469A (en) 2000-03-14
PL308643A1 (en) 1995-08-21
WO1994010178A1 (en) 1994-05-11
AU687365B2 (en) 1998-02-26
CN1044247C (zh) 1999-07-21
PL177840B1 (pl) 2000-01-31
IL107431A (en) 1999-05-09
GB9222700D0 (en) 1992-12-09
DE69328436D1 (de) 2000-05-25
FI114638B (sv) 2004-11-30
JP3488457B2 (ja) 2004-01-19
CZ293106B6 (cs) 2004-02-18
SI9300574A (en) 1994-06-30
EP0666862A1 (en) 1995-08-16
FI952063A (sv) 1995-06-27
ATE191914T1 (de) 2000-05-15
US6600035B1 (en) 2003-07-29
HK1012375A1 (en) 1999-07-30
NO951634D0 (no) 1995-04-28
KR100295710B1 (ko) 2001-10-24
IL107431A0 (en) 1994-01-25
NO951634L (no) 1995-04-28
GR3033448T3 (en) 2000-09-29
SA93140373B1 (ar) 2005-06-07
FI952063A0 (sv) 1995-04-28
ES2145064T3 (es) 2000-07-01
US5602250A (en) 1997-02-11
DK0666862T3 (da) 2000-09-11
EP0666862B1 (en) 2000-04-19
CN1143851C (zh) 2004-03-31
SK54095A3 (en) 1995-09-13
AP438A (en) 1995-11-24
RU95110049A (ru) 1997-01-10
MX9306679A (es) 1994-04-29
DE69328436T2 (de) 2000-10-19
CN1289766A (zh) 2001-04-04

Similar Documents

Publication Publication Date Title
HK1012375A1 (en) 6-(substituted methylene) penems and intermediates
AU605103B2 (en) 6-(substituted methylene) penems
HU9400279D0 (en) Publicity pillar
GB2266912B (en) Improved door construction
AU2693088A (en) 6-(substituted methylene) penems
IL104472A0 (en) Substituted hexahydro-azepinones and tetrahydro-benzazepinones
ZA934077B (en) Benzodiazepines
GB9324180D0 (en) Door construction
AU715163C (en) 6-(substituted methylene) penems and intermediates
AU4676897A (en) 6-(substituted methylene) penems and intermediates
AU117953S (en) Door leverset
GB9316647D0 (en) Macrocycles incorporating quinazolinones
AU118518S (en) Receiver
AU117796S (en) Railing
AU117944S (en) Door leverset
AU118346S (en) Receiver
ZA937949B (en) New substituted azetidinones as anti-inflammatory and antidegenerative agents
IL114344A0 (en) Beta-lactam intermediates
GB9224706D0 (en) Door construction
HK1007182A1 (en) Improved door construction
TW341281U (en) Improved door construction
AU115806S (en) Handrail
GB9224950D0 (en) Juggling combination devil stick
AU117945S (en) Door leverset
AU114790S (en) Door